Patent Assignment
Reel/Frame 025084/0001
Security Agreement
Recorded: 2010-10-04
Pages: 8
Assignor
PRESTWICK PHARMACEUTICALS, INC.
Executed: 2010-09-28
Assignee
GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
200 WEST STREET, NEW YORK, NEW YORK, 10282
Covered Properties
(4)
Novel Piperidin-2,6-Dione Bisulphate Salts and Their Use for the Treatment of Stress Related Affective Disorders
Piperidin-2,6-Dione Pamoate Salts and Their Use for the Treatment of Stress-Related Affective Disorders
Derivatives of Glycinergic R(+)-2-Amino-3-Hydroxypropanoic Acid
Piperidin-2, 6-dione pamoate salts and their use for the treatment of affective disorders
Application:
12/382,511 →
Publication:
US 2009/0182012
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 25, 2004
From: GITTOS, MAURICE WARD
To: PRESTWICK PHARMACEUTICALS, INC.
Reel/Frame 015675/0083 →
Assignment of Assignor's Interest
Mar 9, 2005
From: WERMUTH, CAMILLE GEORGES
To: PRESTWICK CHEMICAL, INC.
Reel/Frame 016343/0773 →
Assignment of Assignor's Interest
Mar 10, 2005
From: PRESTWICK CHEMICAL, INC.
To: PRESTWICK SCIENTIFIC CAPITAL, INC.
Reel/Frame 016350/0890 →
Assignment of Assignor's Interest
Mar 11, 2005
From: PRESTWICK SCIENTIFIC CAPITAL, INC.
To: PRESTWICK PHARMACEUTICALS, INC.
Reel/Frame 016354/0424 →
Assignment of Assignor's Interest
Jun 20, 2006
From: CLARENCE-SMITH, KATHLEEN; CONTRERAS, JEAN-MARIE GEORGES; DEYON, LAURENCE NATHALIE; WERMUTH, CAMILLE GEORGES
To: PRESTWICK PHARMACEUTICALS, INC.
Reel/Frame 017818/0689 →
Security Agreement
Jul 31, 2007
From: PRESTWICK PHARMACEUTICALS, INC.
To: MERRILL LYNCH CAPITAL, A DIVISION OF MERRILL LYNCH BUSINESS FINANCIAL SERVICES INC.
Reel/Frame 019605/0664 →
Patent Security Agreement
Jun 10, 2009
From: PRESTWICK PHARMACEUTICALS, INC.
To: J.P. MORGAN CHASE BANK, N.A., TORONTO BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 022804/0321 →
Release of Security Agreement
Oct 6, 2010
From: JPMORGAN CHASE BANK, N.A., TORONTO BRANCH
To: BIOVAIL CORPORATION; PRESTWICK PHARMACEUTICALS, INC.
Reel/Frame 025095/0636 →
Release of Security Agreement
Oct 6, 2010
From: GE BUSINESS FINANCIAL SERVICES, INC.
To: PRESTWICK PHARMACEUTICALS, INC.
Reel/Frame 025102/0710 →
Patent Security Release Agreement
Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: PRESTWICK PHARMACEUTICALS, INC.
Reel/Frame 025950/0097 →
Security Agreement
Jul 18, 2011
From: VALEANT PHARMACEUTICALS INTERNATIONAL, A DELAWARE CORPORATION; ATON PHARMA, INC., A DELAWARE CORPORATION; CORIA LABORATORIES, LTD., A DELAWARE CORPORATION; DOW PHARMACEUTICAL SCIENCES, INC., A DELAWARE CORPORATION
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 026606/0061 →
Change in Name and Country of Incorporation
Aug 9, 2012
From: VALEANT INTERNATIONAL (BARBADOS) SRL
To: VALEANT INTERNATIONAL BERMUDA
Reel/Frame 028757/0052 →
Notice of Succession of Agency
Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
Reel/Frame 073637/0001 →